Published in J Clin Oncol on September 08, 2015
Pathological upstaging and treatment strategy of clinical stage I small cell lung cancer following surgery. J Thorac Dis (2017) 1.38
Targeting bet bromodomain proteins in solid tumors. Oncotarget (2016) 0.89
Small cell lung cancer (SCLC): no treatment advances in recent years. Transl Lung Cancer Res (2016) 0.79
The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer. Oncologist (2016) 0.78
Targeted drugs in small-cell lung cancer. Transl Lung Cancer Res (2016) 0.77
Novel hybrid phenotype revealed in Small Cell Lung Cancer by a transcription factor network model that can explain tumor heterogeneity. Cancer Res (2016) 0.76
Chemotherapy regimens for metastatic nonsmall cell lung cancer: Generating good quality data is important before challenging evidence. Lung India (2016) 0.75
Management of small-cell lung cancer with radiotherapy-a pan-Canadian survey of radiation oncologists. Curr Oncol (2016) 0.75
Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review. PLoS One (2016) 0.75
Small-cell lung cancer: what we know, what we need to know and the path forward. Nat Rev Cancer (2017) 0.75
A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer. Front Oncol (2017) 0.75
Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors. Transl Lung Cancer Res (2017) 0.75